Andrea Heider
- Oncology
- Pathology and Forensic Medicine top 10%
- Genetics top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- N. NiederleH. WilkeGeorgios StamatisAlbert SchmitzMathias RummelGerhard HeilArnold GanserJoachim von Pawel
- Topics
- Lung Cancer Research Studies (5 papers)Cancer therapeutics and mechanisms (4 papers)Neuroendocrine Tumor Research Advances (4 papers)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Andrea Heider
16 papers receiving 283 citations
Peers
Comparison fields: 5 of 56
- Oncology 179
- Pathology and Forensic Medicine 141
- Genetics 106
- Pulmonary and Respiratory Medicine 63
- Molecular Biology 45
Countries citing papers authored by Andrea Heider
This map shows the geographic impact of Andrea Heider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Heider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Heider more than expected).
Fields of papers citing papers by Andrea Heider
This network shows the impact of papers produced by Andrea Heider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Heider. The network helps show where Andrea Heider may publish in the future.
Co-authorship network of co-authors of Andrea Heider
This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Heider. A scholar is included among the top collaborators of Andrea Heider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Heider. Andrea Heider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 19 | |
| 3 | 47 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 22 | |
| 7 | 3 | |
| 8 | 12 | |
| 9 | 1 | |
| 10 | 82 | |
| 11 | 4 | |
| 12 | 22 | |
| 13 | Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial. | 18 |
| 14 | Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. | 22 |
| 15 | 18 | |
| 16 | 6 |
About Andrea Heider
Andrea Heider is a scholar working on Oncology, Dermatology and Pathology and Forensic Medicine, having authored 16 papers that have together received 294 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Genetics (106 citations), Pathology and Forensic Medicine (141 citations) and Oncology (179 citations). Andrea Heider has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include N. Niederle, H. Wilke, Georgios Stamatis, Albert Schmitz, Mathias Rummel, Gerhard Heil, Arnold Ganser, Joachim von Pawel, Christina Balser and Christoph Losem. Their work appears in journals such as Journal of Clinical Oncology, Blood and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.